U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Sodium Bicarbonate Injection
Status: Currently in Shortage
»Date first posted: 03/01/2017
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric

Expand all

Amphastar Pharmaceuticals, Inc. (Reverified 04/09/2025)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1) Available

Exela Pharma Sciences, LLC (Revised 04/15/2025)

Company Contact Information:
828-758-5474 ext. 154

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5001-5) Unavailable 3 weeks > inventory. Demand increase for the drug
Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4) Available
Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4) Available

Fresenius Kabi USA, LLC (Reverified 04/01/2025)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05) Unavailable Backordered. Next release not available at this time. Check wholesalers for inventory Demand increase for the drug
Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50) Available Check wholesalers for inventory

Hospira, Inc., a Pfizer Company (Revised 04/11/2025)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Bicarbonate, Injection, 5 mEq/10 mL (4.2%, 0.5 mEq/mL) Syringes (NDC 0409-5534-14) Unavailable Next Delivery: July 2025; Estimated Recovery: September 2025 Other
Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-6637-14) Unavailable Next Delivery: May 2025; Estimated Recovery: December 2025 Other
Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02) Available
Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01) Available
Sodium Bicarbonate, Injection, 44.6 mEq/50 mL (7.5%, 0.9 mEq/mL) Syringes (NDC 0409-4916-14) Unavailable Next Delivery and Estimated Recovery: December 2028 Other
Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14) Available
Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-35) Unavailable Next Delivery: July 2025; Estimated Recovery: September 2025 Other
Sodium Bicarbonate, Injection, 10 mEq/10 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-4900-14) Unavailable Next Delivery: January 2026; Estimated Recovery: June 2026 Other

Long Grove Pharmaceuticals LLC (Reverified 04/22/2025)

Company Contact Information:
833-268-5559

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 81298-7620-3) Available
Back to Top